Morgan Stanley Previews Walgreens' November Same Store Sales

is scheduled to report its November sales on Wednesday before market open. Ricky Goldwasser of Morgan Stanley is expecting Walgreens to report a total sales comp of 4.2 percent year over year, or 5.6 percent adjusted for calendar day shift impact. The analyst's estimates represent a decrease from the 5.9 percent adjusted comp the company reported in October. Goldwasser's estimates reflects a pharmacy sales comp estimate of 5.7 percent (7.9 percent adjusted) and a pharmacy script comp of 1.7 percent year over year (3.9 percent adjusted), down from an adjusted comp of 4.1 percent in October. The analyst also expects Walgreens to report a front-end comp of 1.3 percent year over year, down from the 2.0 percent the company reported in October. Shares are Overweight rated with a $77 price target.